Skip to main content
Log in

Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO)

  • Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 2. Combined Modalities and Others
  • PSE, Hepatic Function, Hemodynamics
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Since April 1985, we have performed a multidisciplinary therapy consisting of partial splenic embolization (PSE), percutaneous transhepatic obliteration (PTO) or transileocolic vein obliteration (TIO), and endoscopic injection sclerotherapy (EIS) for patients with severe gastroesophageal varices and those with a portacaval shunt associated with portal hypertension. In this study, PSE and percutaneous transhepatic portography (PTP) were performed at the same time in seven liver cirrhosis patients with hypersplenism, gastroesophageal varices, or hepatocellular carcinoma. The changes in portal blood flow/pressure and hemodynamics were examined by a thermodilution method. The effects of PSE on blood biochemical parameters such as the platelet count, ICG R15, redox tolerance index (RTI), and oral glucose tolerance test (75 g OGTT) were also evaluated. PSE induced a decrease in the blood flow of the splenic artery and in the splenic vein pressure without decreasing the portal blood flow. The platelet count in the peripheral blood and the RTI increased significantly. These results suggest the possibility that PSE may reduce the potential perioperative risk in hepatocellular carcinoma complicated with liver cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kawarada Y, Imai T, Iwata M, Yokoi H, Noguchi T, Mizumoto R (1992) Significance of multidisciplinary therapy for hepatocellular carcinoma. Cancer Chemother Pharmacol 31 [Suppl I]:S13

    Google Scholar 

  2. Kinoshita H (1989) Percutaneous transhepatic portography: techniques and clinical usefulness in hepatic, pancreatic and biliary surgery. Kanehara & Co., Ltd., Tokyo, p 63

    Google Scholar 

  3. Lunderquist A, Vang J (1974) Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 291:646

    Google Scholar 

  4. Maddison E (1973) Embolic therapy of hypersplenism. Invest Radiol 8:280

    Google Scholar 

  5. Mori K, Ozawa K, Yamamoto Y, Maki A, Shimahara Y, Kobayashi N, Yamaoka Y, Kumada K (1990) Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 211:438

    Google Scholar 

  6. Mukaiya M, Hirata K (1992) Re-evaluation of hepatic function after the embolization of esophago-gastric varices (in Japanese). Hokkaido Med J 67:752

    Google Scholar 

  7. Tajiri T, Umehara M, Tei J, Kim DY, Aoki N, Yamashita K, Onda M (1985) Transcatheter embolization therapy for esophageal varices and hypersplenism with liver cirrhosis (in Japanese). Jpn J Gastroenterol Surg 86:1227

    Google Scholar 

  8. Ueda T, Isobe Y, Tsutsui T, Aoki Y, Ando M, Ishibashi T (1979) Trans-ileocolic vein obliteration of gastroesophageal varices (in Japanese). J Jpn Soc. Clin Surg 34:685

    Google Scholar 

  9. Yamashiro K, Mukaiya M, Kimura H, Nakano M, Takashima K, Watabe K, Oikawa I, Okazaki Y, Hirata K (1991) Multidisciplinary therapy for gastroesophageal varices mainly treated by TIO (trans-ileocolic vein obliteration of gastroesophageal varices) in Japanese). Prog Abdominal Emergency 11:635

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukaiya, M., Hirata, K., Yamashiro, K. et al. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother. Pharmacol. 33 (Suppl 1), S37–S41 (1994). https://doi.org/10.1007/BF00686666

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686666

Keywords

Navigation